HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RXP03

structure in first source

Also Known As:

Z-Phe-psi(PO2-CH2)-pPhe-Trp-NH2; benzyloxycarbonyl-Phe-psi(PO2-CH2)-pPhe-Trp-NH2

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - RXP03: 1

Experts

1.	Andarawewa, Kumari L: 1 article (02/2005)
2.	Beau, Fabrice: 1 article (02/2005)
3.	Boulay, Anne: 1 article (02/2005)
4.	Dive, Vincent: 1 article (02/2005)
5.	Guerin, Eric: 1 article (02/2005)
6.	Matziari, Magdalini: 1 article (02/2005)
7.	Rio, Marie-Christine: 1 article (02/2005)
8.	Rousseau, Bernard: 1 article (02/2005)
9.	Yiotakis, Athanasios: 1 article (02/2005)

Related Diseases

1.	Neoplasms (Cancer) 02/20/2005 - "Efficacy of RXP03 on the growth of primary tumors induced by s.c. " 02/20/2005 - "Strikingly, RXP03 treatment started 6 days after the C(26) injection and continued until day 18 led to stimulation of tumor growth, as compared to control. " 02/20/2005 - "Short treatments with RXP03 100 microg/day, 3 to 7 days after C(26) inoculation, were more effective on tumor growth than continuous treatment over 18 days. " 02/20/2005 - "Tumor volumes in mice treated for 18 days with 50, 100 and 150 microg/day of RXP03 were decreased compared with control tumor volumes, 100 microg/day being the most effective dose. " 02/20/2005 - "injection into mice, most of the RXP03 was recovered intact in plasma, feces (biliary excretion) and tumor tissue. "
2.	Carcinoma (Carcinomatosis) 02/20/2005 - "injection of C(26) colon carcinoma cells in mice was observed to depend both on RXP03 doses and treatment schedules. "

Related Drugs and Biologics

1.	Matrix Metalloproteinase Inhibitors
2.	Therapeutic Uses
3.	Matrix Metalloproteinases (MMPs)